CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

NICE's decision comes shortly after Lilly reported the first head-to-head clinical data, showing that Mounjaro was more effective than its arch-rival Wegovy (semaglutide) from Novo Nordisk in ...